-+ 0.00%
-+ 0.00%
-+ 0.00%
MediWound Hosts Virtual Expert Event on EscharEx Phase III Study
Share
Listen to the news
MediWound Hosts Virtual Expert Event on EscharEx Phase III Study
  • MediWound will host a virtual key opinion leader event on December 2, 2026, at 11 a.m. Eastern Time.
  • Discussion will cover EscharEx clinical evidence, the pivotal Phase III VALUE study in venous leg ulcers and U.S. commercial potential.
  • The program will examine assumptions behind Alira Health's estimated $1.05 billion in U.S. annual peak sales potential for EscharEx.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediWound Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160800PRIMZONEFULLFEED9878216) on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending